TGFB1 and neoplasm: The brain TME harbors numerous anti-inflammatory cytokines and stimulatory ligands secreted by tumor cells and surrounding immune cells, such as IL-4, IL-10, and TGF-β.54 These molecules diminish antitumor activity of infiltrating immune cells and thus enable tumor progression.